Where Are We Now With Bilirubin as a Marker of Vascular Risk?

Abstract

Get full access to this article

View all access options for this article.

References

Breimer

. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol Carcinog. 1990;3(4):188–197.

Barnes

Lindahl

. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet. 2004;38:445–476.

Ohnaka

Kono

. Bilirubin, cardiovascular diseases and cancer: epidemiological perspectives. Expert Rev Endocrinol Metab. 2010;5(6):891–904.

Breimer

Mikhailidis

. Is bilirubin a marker of vascular disease and/or cancer and is it a potential therapeutic target? Curr Pharm Des. 2011;17(33):3644–3655.

Breimer

. Does bilirubin act as a free radical quencher of clinical significance in neonates and children? J Pediatr Biochem. 2010;1(1):29–37.

McCord

Fridovich

. Superoxide dismutase: the first twenty years (1968-1988). Free Radic Biol Med. 1988;5(5-6):363–369.

Karlsson

Marklund

. Extracellular superoxide dismutase in the vascular system of mammals. Biochem J. 1988;255(1):223–228.

Frei

Stocker

Ames

. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA. 1988;85(24):9748–9752.

Steinberg

Parthasarathy

Carew

Khoo

Witztum

. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320(14):915–924.

10.

Stocker

Yamamoto

McDonagh

Glazer

Ames

. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235(4792):1043–1046.

11.

Horsfall

Nazareth

Petersen

. Cardiovascular events as a function of serum bilirubin levels in a large statin-treated cohort. Circulation. 2012;126(22):2556–2564.

12.

Chan

O’Connell

Sullivan

. Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study [published online January 17, 2013]. Diabetologia. 2013.

13.

Breimer

Wannamethee

Ebrahim

Shaper

. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem. 1995;41(10):1504–1508.

14.

Fulks

Stout

Dolan

. Mortality associated with bilirubin levels in insurance applicants. J Insur Med. 2009;41(1):49–53.

15.

Fulks

Stout

Dolan

. Albumin and all-cause mortality risk in insurance applicants. J Insur Med. 2010;42(1):11–17.

16.

Halliwell

. Albumin—an important extracellular antioxidant? Biochem Pharmacol. 1988;37(4):569–571.

17.

Mikhailidis

Ganotakis

. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7(3):125–137.

18.

Ganotakis

Vrentzos

Gazi

. Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation. In Vivo. 2007;21(4):685–694.

19.

Kronenberg

. Association of bilirubin with cardiovascular outcomes: more hype than substance? Circ Cardiovasc Genet. 2010;3(4):308–310.

20.

Breimer

Mikhailidis

. Could carbon monoxide and bilirubin be friends as well as foes of the body? Scand J Clin Lab Invest. 2010;70(1):1–5.

21.

Katsiki

Karagiannis

Mikhailidis

. Diabetes, bilirubin and amputations: is there a link? [published online January 27, 2013]. Diabetologia. 2013.

22.

Ames

Cathcart

Schwiers

Hochstein

. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA. 1981;78(11):6858–6862.

23.

Katsiki

Karagiannis

Athyros

Mikhailidis

. Hyperuricaemia: more than just a cause of gout? [published online October 1, 2012]. J Cardiovasc Med (Hagerstown). 2012.

24.

Temme

Zhang

Schouten

Kesteloot

. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control. 2001;12(10):887–894.

25.

Theobald

Bygren

Carstensen

Hauffman

Engfeldt

. Effects of an assessment of needs for medical and social services on long-term mortality: a randomized controlled study. Int J Epidemiol. 1998;27(2):194–198.